JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265104

Human LRRC41 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LRRC41 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1.

View Alternative Names

Leucine rich repeat containing 41, Leucine rich repeat containing protein 41, MUF1, PP7759, elongin BC interacting leucine rich repeat protein

1 Images
Sanger Sequencing - Human LRRC41 knockout HeLa cell line (AB265104)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRRC41 knockout HeLa cell line (AB265104)

Homozygous : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265104-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265104 Human LRRC41 knockout HeLa cell line", "number":"AB265104-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265104-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265104 Human LRRC41 knockout HeLa cell line", "number":"AB265104-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LRRC41
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The LRRC41 protein also known as LRR41 or Leucine-Rich Repeat Containing Protein 41 has distinct mechanical roles in cellular processes. Structurally this protein consists of several leucine-rich repeats that facilitate protein-protein interactions. It has a molecular mass of approximately 59 kDa. LRRC41 is widely expressed in human tissues especially in the brain and heart indicating a broad functional importance in these areas.
Biological function summary

LRRC41 plays an essential role in cellular signaling and regulation. It may function as part of larger protein complexes facilitating various regulatory functions. The protein contributes significantly to the regulation of cell cycle and apoptosis among other cellular processes. Its interactions within the cell modulate the signaling pathways that control these vital processes enabling the cell to respond to different stimuli effectively.

Pathways

The LRRC41 protein is involved in the modulation of the MAPK signaling pathway. This pathway is important for transducing extracellular signals into intracellular responses and it is important in cell growth and differentiation. LRRC41 interacts with proteins within this pathway such as RAF1 and MEK to influence signal transduction events. Its involvement in these pathways highlights its role in maintaining cellular homeostasis and responding to environmental changes.

LRRC41 has been implicated in various conditions including cancer and neurodegenerative disorders. In cancer its altered expression can affect cell proliferation pathways linking it to the progression of certain tumors. In neurodegenerative diseases LRRC41 may interact with proteins involved in cellular stress responses such as huntingtin in Huntington's disease. These associations emphasize the relevance of LRRC41 in both research and clinical settings as understanding its role could lead to therapeutic advancements.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com